Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1997 Jan;50(1):13–15. doi: 10.1136/jcp.50.1.13

Fibrinogen and cardiovascular disease.

T W Meade 1
PMCID: PMC499704  PMID: 9059348

Full text

PDF
13

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Banerjee A. K., Pearson J., Gilliland E. L., Goss D., Lewis J. D., Stirling Y., Meade T. W. A six year prospective study of fibrinogen and other risk factors associated with mortality in stable claudicants. Thromb Haemost. 1992 Sep 7;68(3):261–263. [PubMed] [Google Scholar]
  2. Ernst E., Resch K. L. Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann Intern Med. 1993 Jun 15;118(12):956–963. doi: 10.7326/0003-4819-118-12-199306150-00008. [DOI] [PubMed] [Google Scholar]
  3. Gaffney P. J., Wong M. Y. Collaborative study of a proposed international standard for plasma fibrinogen measurement. Thromb Haemost. 1992 Oct 5;68(4):428–432. [PubMed] [Google Scholar]
  4. Goldbourt U., Behar S., Reicher-Reiss H., Agmon J., Kaplinsky E., Graff E., Kishon Y., Caspi A., Weisbort J., Mandelzweig L. Rationale and design of a secondary prevention trial of increasing serum high-density lipoprotein cholesterol and reducing triglycerides in patients with clinically manifest atherosclerotic heart disease (the Bezafibrate Infarction Prevention Trial). Am J Cardiol. 1993 Apr 15;71(11):909–915. doi: 10.1016/0002-9149(93)90905-r. [DOI] [PubMed] [Google Scholar]
  5. Gould A. L., Rossouw J. E., Santanello N. C., Heyse J. F., Furberg C. D. Cholesterol reduction yields clinical benefit. A new look at old data. Circulation. 1995 Apr 15;91(8):2274–2282. doi: 10.1161/01.cir.91.8.2274. [DOI] [PubMed] [Google Scholar]
  6. Hamsten A., Iselius L., de Faire U., Blombäck M. Genetic and cultural inheritance of plasma fibrinogen concentration. Lancet. 1987 Oct 31;2(8566):988–991. doi: 10.1016/s0140-6736(87)92557-8. [DOI] [PubMed] [Google Scholar]
  7. Hicks R. C., Ellis M., Mir-Hasseine R., Higman D. J., Nott D., Greenhalgh R. M., Powell J. T. The influence of fibrinogen concentration on the development of vein graft stenoses. Eur J Vasc Endovasc Surg. 1995 May;9(4):415–420. doi: 10.1016/s1078-5884(05)80009-7. [DOI] [PubMed] [Google Scholar]
  8. Humphries S. E., Cook M., Dubowitz M., Stirling Y., Meade T. W. Role of genetic variation at the fibrinogen locus in determination of plasma fibrinogen concentrations. Lancet. 1987 Jun 27;1(8548):1452–1455. doi: 10.1016/s0140-6736(87)92205-7. [DOI] [PubMed] [Google Scholar]
  9. Kannel W. B., Wolf P. A., Castelli W. P., D'Agostino R. B. Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA. 1987 Sep 4;258(9):1183–1186. [PubMed] [Google Scholar]
  10. Koster T., Rosendaal F. R., Reitsma P. H., van der Velden P. A., Briët E., Vandenbroucke J. P. Factor VII and fibrinogen levels as risk factors for venous thrombosis. A case-control study of plasma levels and DNA polymorphisms--the Leiden Thrombophilia Study (LETS). Thromb Haemost. 1994 Jun;71(6):719–722. [PubMed] [Google Scholar]
  11. Meade T. W., Imeson J., Stirling Y. Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease. Lancet. 1987 Oct 31;2(8566):986–988. doi: 10.1016/s0140-6736(87)92556-6. [DOI] [PubMed] [Google Scholar]
  12. Meade T. W., Mellows S., Brozovic M., Miller G. J., Chakrabarti R. R., North W. R., Haines A. P., Stirling Y., Imeson J. D., Thompson S. G. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet. 1986 Sep 6;2(8506):533–537. doi: 10.1016/s0140-6736(86)90111-x. [DOI] [PubMed] [Google Scholar]
  13. Meade T. W., North W. R., Chakrabarti R., Stirling Y., Haines A. P., Thompson S. G., Brozovié M. Haemostatic function and cardiovascular death: early results of a prospective study. Lancet. 1980 May 17;1(8177):1050–1054. doi: 10.1016/s0140-6736(80)91498-1. [DOI] [PubMed] [Google Scholar]
  14. Meade T. W., Stirling Y., Thompson S. G., Vickers M. V., Woolf L., Ajdukiewicz A. B., Stewart G., Davidson J. F., Walker I. D., Douglas A. S. An international and interregional comparison of haemostatic variables in the study of ischaemic heart disease. Report of a working group. Int J Epidemiol. 1986 Sep;15(3):331–336. doi: 10.1093/ije/15.3.331. [DOI] [PubMed] [Google Scholar]
  15. Montalescot G., Ankri A., Vicaut E., Drobinski G., Grosgogeat Y., Thomas D. Fibrinogen after coronary angioplasty as a risk factor for restenosis. Circulation. 1995 Jul 1;92(1):31–38. doi: 10.1161/01.cir.92.1.31. [DOI] [PubMed] [Google Scholar]
  16. Wilhelmsen L., Svärdsudd K., Korsan-Bengtsen K., Larsson B., Welin L., Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med. 1984 Aug 23;311(8):501–505. doi: 10.1056/NEJM198408233110804. [DOI] [PubMed] [Google Scholar]
  17. Woodhouse P. R., Khaw K. T., Plummer M., Foley A., Meade T. W. Seasonal variations of plasma fibrinogen and factor VII activity in the elderly: winter infections and death from cardiovascular disease. Lancet. 1994 Feb 19;343(8895):435–439. doi: 10.1016/s0140-6736(94)92689-1. [DOI] [PubMed] [Google Scholar]
  18. Yarnell J. W., Baker I. A., Sweetnam P. M., Bainton D., O'Brien J. R., Whitehead P. J., Elwood P. C. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies. Circulation. 1991 Mar;83(3):836–844. doi: 10.1161/01.cir.83.3.836. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES